IHS Chemical Week

Regions :: Western Europe :: Germany

Merck KGaA increases commitment to venture capital fund for start-up biotech firms to €100 million

7:05 AM MDT | May 16, 2013 | Deepti Ramesh

Merck KGaA says it will increase its commitment to its strategic corporate venture capital fund MS Ventures to €100 million ($129 million). MS Ventures is the corporate venture capital fund of Merck Serono, the biopharmaceutical division of Merck. MS Ventures was originally established in March 2009 with a €40 million commitment to invest in emerging biotechnology companies. The new increased commitment secures a long term mandate and will allow MS Ventures to significantly expand its investment activities while still focused on Merck Serono’s...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa